CERS- There is substantial Market for PI Platelets关于NASDAQ:CERS由mazdaki提供

with serial FDA approvals, there will be institutional buyers accumulating this stock. Started an initial position and will add on weakness.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。